Riot Platforms, Inc. — Director's Dealing 2012

Aug 7, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AspenBio Pharma, Inc. (APPY)
CIK: 0001167419
Period of Report: 2012-08-03

Reporting Person: SCHOETTLER GAIL (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-08-03	Common Stock	P	2500	$1.58	Acquired	3000	Direct

Footnotes

F1: Reflects a one-for-five reverse stock split effected July 28, 2011 and a one-for-six reverse stock split effected June 20, 2012.